threonine has been researched along with Carcinoma, Signet Ring Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olgun, A | 1 |
| Frolov, SA; Karpukhin, AV; Kashnikov, VN; Liubchenko, LN; Muzaffarova, TA; Pospekhova, NI; Shelygin, IuA; Shubin, VP; Tsukanov, AC | 1 |
2 other study(ies) available for threonine and Carcinoma, Signet Ring Cell
| Article | Year |
|---|---|
Selective targeting of signet ring cell adenocarcinomas.
Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carcinoma, Signet Ring Cell; Cell Line, Tumor; Humans; Molecular Targeted Therapy; Mucins; Research Design; Threonine | 2019 |
[Molecular genetics study of hereditary predisposition to diffuse gastric cancer in Russian patients].
Topics: Adult; Antigens, CD; Cadherins; Carcinoma, Signet Ring Cell; Cysteine; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Molecular Biology; Pedigree; Polymorphism, Single Nucleotide; Russia; Sequence Deletion; Stomach Neoplasms; Threonine | 2013 |